• Mycophenolate led to improvements in patients with systemic sclerosis-related interstitial lung disease

    4 monthes ago - By Healio

    Compared with placebo, treatment with mycophenolate was linked with improvements in physiologic measures and dyspnea in patients with systemic sclerosis-related interstitial lung disease, according to recently published data.Elizabeth R. Volkmann, MD, in the Department of Medicine at the University of California David Geffen School of Medicine, and colleagues included 61 patients enrolled in the placebo group of Scleroderma Lung Study I - which randomized patients to oral cyclophosphamide or placebo for 1 year - and 61 patients enrolled in the mycophenolate group of SLS II, which...
    Read more ...